Stomach Cancer Clinical Trials
Stomach cancer clinical trials are important research studies that help physicians evaluate the effectiveness of new treatment approaches. Patients who are being treated for stomach cancer at Moffitt Cancer Center may be advised to consider opportunities to participate in suitable clinical trials during the course of their treatments. We encourage our patients to explore all of their options, which may include beneficial new therapies that are not yet available outside of clinical trial settings.
As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt is a well-respected leader in cancer research. Our stomach cancer clinical trials incorporate the collaborative expertise of our multispecialty team of medical professionals and provide us with a means to compare the effectiveness of current treatments with promising new options like:
- Immunotherapy drugs
- Combinations of conventional chemotherapies
- Novel molecularly targeted therapies
Additionally, the researchers and clinicians at Moffitt are investigating biomarkers that can help identify new stomach cancer treatments. We are also studying potential causes of resistance to new therapies.
It’s important to remember that all of today’s most widely recommended treatments for stomach cancer were once available only through research studies. If you are interested in exploring clinical trials, you do not need a referral to consult with the stomach cancer team at Moffitt. We can answer your questions and provide information about all of your treatment options, including both clinical trials and the current standard of care.
To learn more about the stomach cancer clinical trials available at Moffitt Cancer Center, call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. Our clinical trial navigators can help you find out if a trial is right for you, and no referrals are necessary.